Nova Healthcare has launched a new, private radiotherapy service for the treatment of lung metastases – Stereotactic Ablative Radiotherapy (SABR).
SABR is a non-invasive, advanced radiotherapy technique that delivers an ablative dose of radiation over a small number of outpatient treatment sessions, with the aim of improving tumour control and reducing side effects to other tissues.
This technique is widely used for the treatment of lung metastases in North America, Europe and Asia with proven high rates of local tumour control and typically very low rates of side effects.
The service is led by Dr Kevin Franks and Dr Peter Dickinson – Consultant Clinical Oncologists at Leeds Cancer Centre and Nova Healthcare.
Dr Kevin Franks is one of the leading SABR clinicians in the UK, having completed a SABR Research Fellowship at the Princess Margaret Hospital in Toronto prior to his appointment as a consultant in Leeds. He was a founding member of the UK SABR consortium and is currently Chief and Co-Investigator on a number of clinical trials in this area.
Dr Peter Dickinson is a key member of the Leeds Lung SABR team and will be leading the Leeds Lung SABR programme for the treatment of early-stage metastasis. He completed a technical radiotherapy research fellowship at the Christie Hospital in Manchester prior to his consultant post in Leeds.